STAT6: Multidimensional analysis from hematopoietic immune regulation to pathogenesis mechanisms and therapeutic targets in hematologic malignancies
Annals of Hematology · 2026
DOI: 10.1007/s00277-026-06932-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of Hematology, 2026. Verfasst von Shuni Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China. Hauptthemen laut MEDLINE: STAT6 Transcription Factor, Hematologic Neoplasms, Neoplasm Proteins, Hematopoiesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2025 "innovation star" project for graduate students in Colleges and universities in Gansu Province, National Natural Science Foundation of China, Scientific Research Project of Gansu Province.
Abstract (Originalsprache)
Signal Transduction and Activation of Transcription 6 (STAT6) is a key molecule in the Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signaling pathway. Primarily induced by Interleukin-4(IL-4) and Interleukin-13(IL-13), STAT6 undergoes phosphorylation and translocates to the nucleus, where it regulates gene transcription. While the abnormal activation and oncogenic functions of STAT6 in various solid tumors are well documented, its precise biological role in the hematopoietic system has not yet been systematically investigated. Compared with solid tumors, STAT6 activation in hematological malignancies occurs with the Type 2 T helper cell (Th2-type) immune microenvironment that it mediates, which is probably a unique pathogenic mechanism. This review, therefore, delves into the multifunctionality of STAT6 within the hematopoietic system (including viral infection and immune regulation) and hematologic malignancies, as well as its impact on chemotherapy resistance. The aim is to provide a theoretical basis for understanding the biological functions of STAT6 and developing new therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China.
- Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China. wuchy0909@163.com.
Förderung
- 2025 "innovation star" project for graduate students in Colleges and universities in Gansu Province
- National Natural Science Foundation of China
- Scientific Research Project of Gansu Province
- CuiYing postgraduate tutor' training program of Lanzhou University Second Hospital
- the Key Incubation Project Funds of the second hospital & clinical medical school, lanzhou university
- Gansu Provincial Natural Science Foundation of China
- CuiYing postgraduate tutor’ training program of Lanzhou University Second Hospital
Zitieren
APA
Zhang, S., Xiong, S., Liu, X., Cao, J., Yue, N., & Wu, C. (2026). STAT6: Multidimensional analysis from hematopoietic immune regulation to pathogenesis mechanisms and therapeutic targets in hematologic malignancies. Annals of Hematology. https://doi.org/10.1007/s00277-026-06932-2
Vancouver
Zhang S, Xiong S, Liu X, Cao J, Yue N, Wu C. STAT6: Multidimensional analysis from hematopoietic immune regulation to pathogenesis mechanisms and therapeutic targets in hematologic malignancies. Annals of Hematology. 2026. doi:10.1007/s00277-026-06932-2
BibTeX
@article{Zhang2026,
author = {Zhang, Shuni and Xiong, Shuzhen and Liu, Xinyang and Cao, Jiajia and Yue, Ningning and Wu, Chongyang},
title = {STAT6: Multidimensional analysis from hematopoietic immune regulation to pathogenesis mechanisms and therapeutic targets in hematologic malignancies},
journal = {Annals of Hematology},
year = {2026},
doi = {10.1007/s00277-026-06932-2}
}
EUVIMED